NCT06389266 Network-Targeted Neuromodulation for Nicotine Dependence in Schizophrenia Status COMPLETED Phase NA
NCT06387771 Evaluation of Tolcapone as a Cognitive Enhancer in Schizophrenia Status RECRUITING Phase PHASE2
NCT06386588 The Effects of Auditory Stimulation During Sleep on Brain Networks in Schizophrenia Status RECRUITING Phase NA
NCT06376734 Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness Status RECRUITING Phase PHASE2
NCT06372210 A Trial to Assess a Wearable Patch's Functioning to Detect Medication Ingestion Status COMPLETED Phase NA
NCT06361667 Culture and Well-being: Art as Prescription Therapy ("Art on Prescription") Status COMPLETED Phase NA
NCT06361407 Sensory and Cognitive Predictions, and Their Disruptions in Schizophrenia Status RECRUITING Phase NA
NCT06356389 A Clinical Trial to Evaluate Safety, Tolerance and Pharmacokinetics of JX11502MA Capsule in Patients With Schizophrenia. Status COMPLETED Phase PHASE1/PHASE2
NCT06347848 The Effect of Psychoeducation Focused on Reducing Internalized Stigma Status NOT_YET_RECRUITING Phase NA
NCT06345963 Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1) Status RECRUITING Phase NA
NCT06340789 Neurotransmitters in Treatment Resistant Schizophrenia Patients With add-on Sodium Benzoate Status NOT_YET_RECRUITING Phase PHASE2
NCT06336616 Getting Out of the House: Using Behavioral Activation to Increase Community Participation Status RECRUITING Phase NA
NCT06326840 Clinical Efficacy and Adverse Reactions of Antipsychotic Treatment Status COMPLETED Phase NA
NCT06315972 Combining Clemastine and Aerobic Exercise to Treat Cognitive Dysfunction in Schizophrenia by Targeting Myelin Plasticity Status NOT_YET_RECRUITING Phase PHASE2
NCT06315283 An Open-Label Trial to Assess the Comparative Bioavailability of TV-44749 to Oral Olanzapine in Participants With Schizophrenia Status COMPLETED Phase PHASE1
NCT06315049 Music Therapy to Reduce Anxiety in Community-Dwelling Individuals With Severe Mental Illness Status COMPLETED Phase NA
NCT06304233 The Protein Disrupted in Schizophrenia 1 (DISC1) as a Novel Biomarker for Cardiac Disease Status ACTIVE_NOT_RECRUITING Phase N/A